DRI Healthcare Trust (TSE:DHT.UN) Trading Up 38.3%

DRI Healthcare Trust (TSE:DHT.UNGet Free Report)’s stock price rose 38.3% during mid-day trading on Monday . The stock traded as high as C$17.43 and last traded at C$17.33. Approximately 29,555 shares traded hands during trading, a decline of 15% from the average daily volume of 34,784 shares. The stock had previously closed at C$12.53.

Analysts Set New Price Targets

DHT.UN has been the topic of several recent analyst reports. Stifel Nicolaus boosted their target price on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the company a “buy” rating in a research note on Friday, March 1st. National Bankshares boosted their target price on shares of DRI Healthcare Trust from C$22.00 to C$23.50 and gave the company an “outperform” rating in a research note on Friday, March 1st. CIBC boosted their price target on shares of DRI Healthcare Trust from C$19.00 to C$19.50 and gave the company an “outperform” rating in a report on Friday, March 1st. Scotiabank boosted their price target on shares of DRI Healthcare Trust from C$22.00 to C$24.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Finally, Raymond James upgraded shares of DRI Healthcare Trust from an “outperform” rating to a “strong-buy” rating and boosted their price target for the company from C$22.00 to C$24.00 in a report on Friday, March 1st. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of C$21.83.

View Our Latest Analysis on DRI Healthcare Trust

DRI Healthcare Trust Stock Performance

The stock has a fifty day simple moving average of C$15.55.

About DRI Healthcare Trust

(Get Free Report)

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Recommended Stories

Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.